CMIC Group Supports Clinical Trials and Manufacturing of Influenza Antiviral Drug “Avigan® Tablet” and Contributes to Accelerating Provision for COVID-19 Patients
TOKYO--(BUSINESS WIRE)--#Avigan--CMIC HOLDINGS Co., Ltd. (Head Office: Tokyo, Minato-ku, Representative Director & CEO Kazuo Nakamura, hereafter “CMIC”) announced today that...






